MediWound Ltd. (MDWD)
12.84
-0.14
(-1.04%)
USD |
NASDAQ |
Aug 26, 11:32
MediWound Shareholders Equity (Quarterly) : 35.64M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.64M |
| March 31, 2026 | 41.42M |
| December 31, 2025 | 43.63M |
| September 30, 2025 | 50.16M |
| June 30, 2025 | 20.12M |
| March 31, 2025 | 31.27M |
| December 31, 2024 | 31.15M |
| September 30, 2024 | 34.24M |
| June 30, 2024 | 17.87M |
| March 31, 2024 | 23.20M |
| December 31, 2023 | 31.60M |
| September 30, 2023 | 33.05M |
| June 30, 2023 | 34.93M |
| March 31, 2023 | 33.30M |
| December 31, 2022 | 10.91M |
| September 30, 2022 | 1.656M |
| June 30, 2022 | -2.235M |
| March 31, 2022 | 1.945M |
| December 31, 2021 | -4.582M |
| September 30, 2021 | -0.821M |
| June 30, 2021 | 2.118M |
| March 31, 2021 | 4.816M |
| December 31, 2020 | 7.272M |
| September 30, 2020 | 8.617M |
| June 30, 2020 | 10.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 12.89M |
| December 31, 2019 | 15.17M |
| September 30, 2019 | 18.32M |
| June 30, 2019 | 18.18M |
| March 31, 2019 | 5.141M |
| December 31, 2018 | 8.972M |
| September 30, 2018 | -1.778M |
| June 30, 2018 | 1.03M |
| March 31, 2018 | 5.028M |
| December 31, 2017 | 9.62M |
| September 30, 2017 | 11.78M |
| June 30, 2017 | -0.356M |
| March 31, 2017 | 3.781M |
| December 31, 2016 | 7.77M |
| September 30, 2016 | 8.872M |
| June 30, 2016 | 13.97M |
| March 31, 2016 | 20.56M |
| December 31, 2015 | 23.47M |
| September 30, 2015 | 30.55M |
| June 30, 2015 | 33.65M |
| March 31, 2015 | 37.15M |
| December 31, 2014 | 42.87M |
| September 30, 2014 | 48.69M |
| June 30, 2014 | 52.43M |
| March 31, 2014 | 57.31M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 7.753B |
| RedHill Biopharma Ltd. | -- |
| Purple Biotech Ltd. | 12.27M |
| Sol-Gel Technologies Ltd. | 48.10M |
| PolyPid Ltd. | 5.388M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 71.88M |
| Total Liabilities (Quarterly) | 27.45M |
| Debt to Equity Ratio | 0.2676 |
| Current Ratio | 2.316 |
| Net Debt Paydown Yield | -0.26% |